Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences

Severe menstrual pain is not normal: adolescent dysmenorrhoea as a marker of future chronic pain

Poli-Neto OB. et al, (2026), Revista Brasileira de Ginecologia e Obstetrícia, 48

Mezigdomide reverses T-cell exhaustion through degradation of IKZF1/IKZF3 and reinvigoration of cytokine production pathways.

Chiu H. et al, (2026), Blood

Early plasma proteomic alterations precede amyloidosis diagnosis, reflecting cardiac and immune dysregulation

Hasheminasab SA. et al, (2026)

Targeting fibroblasts in immune mediated inflammatory diseases: a cellular basis for cure?

Xenophontos M. et al, (2026), Rheumatology (Oxford)

Zwitterionic Lipid Nanotherapeutics from Mulberry for Oral Treatment of Diabetic Colitis.

Cao Y. et al, (2026), ACS Nano

Long-term risk of knee replacement after ACL reconstruction using the contralateral knee as an internal control: a National Hospital Episode Statistics database study of 135 881 patients.

Hennessy C. et al, (2026), Br J Sports Med

Chemical screens identify HDAC6 as an epigenetic vulnerability in acquired Temozolomide-resistant models of glioblastoma

Aksu FS. et al, (2026)

Point-of-care ultrasound-guided regional anaesthesia: pericapsular nerve group (PENG) block for patients with hip fracture

Maffeis R. et al, (2026), Emergency Medicine Journal

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Chen LY. et al, (2026), Blood

Losartan and Prednisolone for Post-COVID Syndrome and Cardiac Inflammation: A Randomized, Double-Blind, Placebo-Controlled Trial

Puntmann VO. et al, (2026), Nature Communications

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients

Png ME. et al, (2026), JAMA Network Open, 9, e2612381 - e2612381

Volumetric Additive Manufacturing of Embedded Channels for Studying Flow and Permeation in Hydrogel Systems

Stride E., (2026), Advanced Materials Technologies

Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platform: reply.

Eshak N. et al, (2026), Rheumatology (Oxford), 65

The role of HMGB1 in myocardial infarction

Lee TY., (2026)

Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic Arthritis

Ritchlin CT. et al, (2026), Advances in Therapy

Anatomic predisposition and neurologic vulnerability to brachial plexus birth injury: a contemporary narrative review.

Beaumont HO. et al, (2026), J Hand Surg Eur Vol

Past patients’ long-term experiences with complications, revision, and contralateral knee replacement after primary TKA can meaningfully inform the journey of new patients

Revaz M. et al, (2026)

Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours.

Glasspool R. et al, (2026), Invest New Drugs

Age and symptom severity as predictors of outcomes following shockwave therapy in Achilles tendinopathy : a single-centre observational study.

Hutchison A-M. et al, (2026), Bone Joint J, 108-B, 650 - 656

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients.

Png ME. et al, (2026), JAMA Netw Open, 9

Search results

Showing results for